Delivery Order SPE2DB20D1004-SPE2DB24FF2Z4
- Not listed
- This federal contract award is for the delivery of Trelegy Ellipta pharmaceutical products to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor, which is a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $5,243.57 and runs through January 26, 2024. It is a firm-fixed-price delivery order contract, with no set-aside designation. Amerisourcebergen Drug Corp also holds a significant...
- This federal contract award is for the pharmaceutical product Trelegy Ellipta, which is being procured by the Defense Logistics Agency (DLA) through a delivery order. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,210.02 and a completion date of July 27, 2023. It is a firm fixed-price contract, with no set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of the...
- This federal contract award is for the delivery of Trelegy Ellipta, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $9,891.00 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has an ultimate completion date of January 17, 2024 and was awarded on January 16, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- The federal contract award is for the pharmaceutical product Trelegy Ellipta, awarded by the Defense Logistics Agency (DLA) to the prime contractor AmerisourceBergen Drug Corp. The contract has a ceiling value of $2,720.73 and is a firm fixed price delivery order with a completion date of March 5, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that specializes in supplying medical products...
- This federal contract award, valued at $8,528.22, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a delivery order for the pharmaceutical product Trelegy Ellipta 100-62.5-25 60S. The contract has an ultimate completion date of November 12, 2024 and was awarded on November 8, 2024. There was no set-aside designation for this contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
- This federal contract award is for the delivery of pharmaceutical products, specifically Trelegy Ellipta 100-62.5-25 60S, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $8,825.32 and an ultimate completion date of October 22, 2021. It is a delivery order contract with a firm fixed price pricing type. Amerisourcebergen Drug Corp is a subsidiary...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Trelegy Ellipta pharmaceutical products, valued at $2,680.83. The award was made by the Defense Logistics Agency (DLA), a defense agency that provides logistics, acquisition, and technical services to the U.S. Armed Forces and other government agencies. This is a delivery order contract with a firm-fixed price pricing type. The contract has a completion date of June 18, 2024 and was...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $17,584.21 for the pharmaceutical product Trelegy Ellipta 200-62.5-25 60s. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of May 10, 2024. The contract is a firm fixed-price delivery order and was not set aside for any specific business type. Amerisourcebergen holds a significant $999,999,999 Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Trelegy Ellipta 100-62.5-25 60S medication. The $5,456.23 firm fixed-price delivery order is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,417.89 firm-fixed-price delivery order is for the pharmaceutical product Trelegy Ellipta 100-62.5-25 60S. The contract has an ultimate completion date of May 16, 2023. This order is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a wide range of pharmaceutical products and...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB24FF2Z4Delivery Order
This federal contract award is for the delivery of pharmaceutical products, specifically the drug Trelegy Ellipta, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,346.04 and is a firm fixed-price delivery order, with a completion date of January 26, 2024. The contract was awarded on January 25, 2024, and there is no set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, serving as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Additionally, Cencora, Inc. maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation, covering similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 1/25/24 |